Tag:
Dengue fever
Latest Headlines
Latest Headlines
Study: Dengue virus research needs to focus on people, not mice
There are no dengue virus vaccines so far, but new research from the University of North Carolina and Vanderbilt University could help speed vaccines to the market.
Navy moves dengue fever vaccine into clinical trials
The Naval Medical Research Center (NMRC) has started a Phase I trial of its dengue virus vaccine, developed in collaboration with Vical .
Inviragen forms dengue partnership with IVI
Vaccine maker Inviragen has signed a memorandum of understanding with the nonprofit International Vaccine Institute (IVI) for further development of dengue vaccines. Currently, Inviragen has a
Sanofi's dengue fever vax progresses in Thai trial
Reuters reports today that Sanofi's experimental vaccine for dengue fever, the most advanced its kind, is making progress in a Thai trial. The vaccine, which is on track to be available in 2014, is
Sanofi plots 2014 launch of new dengue vaccine
Sanofi Pasteur is hoping that its Phase III vaccine for the prevention of dengue fever in children and adults could hit the market by 2014, according to a Reuters report. There are currently no
Sanofi dengue vax enters PhIII
Sanofi Pasteur's dengue vaccine has entered its first Phase III clinical study in Australia. The study is part of a global Phase III clinical study program aimed at advancing the development of a
Inviragen starts Colombian Phase I dengue trial
Inviragen and the Program for the Study and Control of Tropical Diseases have announced a Phase I trial in Colombia of Inviragen's lead vaccine candidate, DENVax. The vaccine should protect against
Inviragen, PharmaJet land $15.5M for needle-free dengue vax
The National Institute of Allergy and Infectious Diseases awarded a five-year, $15.5 million contract to Inviragen and PharmaJet to continue their work on a needle-free dengue vaccine. The disease,
Merck buys vax unit from bankrupt Hawaii Biotech
Merck ( NYSE: MRK ) has agreed to purchase bankrupt Hawaii Biotech 's dengue fever vaccine unit for an undisclosed sum. It's a critical move for Hawaii, which filed for Chapter 11 bankruptcy protection
Sanofi touts dengue fever vaccine data
In a study published in the Journal of Infectious Diseases, Sanofi-Aventis reports that all 66 subjects enrolled in a trial of its dengue fever vaccine were protected from the disease after receiving
